BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rutherford BR, Bailey VS, Schneier FR, Pott E, Brown PJ, Roose SP. INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALS. Depress Anxiety 2015;32:944-57. [PMID: 26437267 DOI: 10.1002/da.22433] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Weimer K, Horing B, Muth ER, Scisco JL, Klosterhalfen S, Enck P. Different Disclosed Probabilities to Receive an Antiemetic Equally Decrease Subjective Symptoms in an Experimental Placebo Study: To Be or Not to Be Sure. Clin Ther 2017;39:487-501. [PMID: 28011248 DOI: 10.1016/j.clinthera.2016.11.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Strawn JR, Dobson ET, Mills JA, Cornwall GJ, Sakolsky D, Birmaher B, Compton SN, Piacentini J, McCracken JT, Ginsburg GS, Kendall PC, Walkup JT, Albano AM, Rynn MA. Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study. J Child Adolesc Psychopharmacol 2017;27:501-8. [PMID: 28384010 DOI: 10.1089/cap.2016.0198] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
3 Keefe JR, Mao JJ, Soeller I, Li QS, Amsterdam JD. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. Phytomedicine 2016;23:1699-705. [PMID: 27912871 DOI: 10.1016/j.phymed.2016.10.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
4 Wollmer MA, Makunts T, Krüger THC, Abagyan R. Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety. Sci Rep 2021;11:24173. [PMID: 34934096 DOI: 10.1038/s41598-021-03713-x] [Reference Citation Analysis]
5 Keefe JR, Amsterdam J, Li QS, Soeller I, DeRubeis R, Mao JJ. Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract for generalized anxiety disorder. J Psychiatr Res 2017;84:90-7. [PMID: 27716513 DOI: 10.1016/j.jpsychires.2016.09.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Strawn JR, Mills JA, Cornwall GJ, Mossman SA, Varney ST, Keeshin BR, Croarkin PE. Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials. J Child Adolesc Psychopharmacol 2018;28:2-9. [PMID: 28846022 DOI: 10.1089/cap.2017.0060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
7 Dobson ET, Strawn JR. Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation. J Child Adolesc Psychopharmacol 2016;26:686-93. [PMID: 27027330 DOI: 10.1089/cap.2015.0192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
8 Agabio R, Baldwin DS, Amaro H, Leggio L, Sinclair JMA. The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev 2021;125:296-313. [PMID: 33454289 DOI: 10.1016/j.neubiorev.2020.12.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rief W. [The role of placebo and nocebo mechanisms in depressive diseases and their treatment]. Nervenarzt 2020;91:675-83. [PMID: 32607602 DOI: 10.1007/s00115-020-00940-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]